You're reading: Reuters: AstraZeneca’s trial illnesses may not be due to COVID-19 shot, says Oxford University

Reuters: AstraZeneca’s trial illnesses may not be due to COVID-19 shot, says Oxford University

By Reuters.

Published Sept. 17, 2020 at 5:14 am

(FILES) In this file photo taken on August 13, 2020, a lab technician sorts blood samples for a COVID-19 vaccination study at the Research Centers of America in Hollywood, Florida.

Photo by AFP

The adverse events that led to a pause in trials evaluating AstraZeneca Plc’s AZN.L COVID-19 vaccine candidate may not have been associated with the vaccine itself, according to a document outlining participant information that was posted online by the Oxford University.